Related Experiment Video
Updated: Mar 25, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Diagnostic Yield and Testing Characteristics of an Invasive Coronary Function Testing Program
Fouad Bitar1,2, Roukoz Abou-Karam1,2, Shoshana Gady1,2
1Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Insights
Invasive coronary function testing (CFT) accurately diagnoses conditions like angina without obstructive coronary arteries (ANOCA) and guides treatment changes in over 70% of patients. This safe, high-yield program improves management for non-obstructive coronary artery disease.
Area of Science:
- Cardiology
- Diagnostic Imaging
- Interventional Cardiology
Background:
- Angina, ischemia, or myocardial infarction without non-obstructive coronary arteries (ANOCA, INOCA, or MINOCA) are frequently underdiagnosed.
- Invasive coronary function testing (CFT), including coronary thermodilution and reactivity testing, offers accurate diagnostic capabilities.
Purpose of the Study:
- To evaluate the diagnostic yield of an invasive CFT program.
- To present findings from coronary thermodilution and reactivity testing in 104 patients.
- To assess changes in patient management following CFT.
Main Methods:
- Retrospective cohort study of 104 consecutive patients undergoing invasive CFT.
- Descriptive statistics used to summarize patient characteristics, diagnostic outcomes, and management changes.
- Analysis included coronary thermodilution and coronary reactivity testing.
Main Results:
- A definitive diagnosis was achieved in 71.2% of patients.
- Diagnoses included epicardial coronary spasm (27%), microvascular spasm (9%), endothelial dysfunction (6%), coronary microvascular dysfunction (CMD) (13%), and mixed phenotypes (17%).
- Management changes occurred in 73% of patients, primarily involving antianginal therapy adjustments.
Conclusions:
- An invasive CFT program can be safely implemented with a high diagnostic yield.
- CFT leads to significant changes in antianginal therapy for patients with non-obstructive coronary artery disease.
- The study highlights the value of CFT in diagnosing and managing complex coronary artery conditions.
Background:
Angina, ischemia, or myocardial infarction without non-obstructive coronary arteries (ANOCA, INOCA, or MINOCA) are common conditions yet often underdiagnosed. Invasive coronary function testing (CFT), which includes coronary thermodilution and coronary reactivity testing, can provide accurate diagnoses and improve patient outcomes.
Aims:
This study describes the diagnostic yield of an invasive CFT program at a single tertiary care center and presents the findings of coronary thermodilution and coronary reactivity testing in the first 104 patients from 2021 to 2025.
Methods:
We conducted a retrospective cohort study of consecutive patients who underwent invasive CFT. Descriptive statistics summarized patient characteristics, diagnostic outcomes, and changes in management following invasive CFT.
Results:
One hundred and four patients (mean age 61.6 ± 10.5 years; 48.1% female) included patients tested ad hoc during an index coronary angiogram (n = 23) or during a scheduled functional assessment (n = 81). Testing indications were post-revascularization angina (39%), ANOCA (35%), INOCA (14%), MINOCA (6%), or heart transplant (5%). Invasive CFT consisted of thermodilution-based coronary flow reserve only (35%), coronary reactivity testing only (10%), or both (55%). A definitive diagnosis was achieved in 74 of 104 patients (71.2%). Of these, 28 (27%) were diagnosed with epicardial coronary spasm, 9 (9%) with microvascular spasm, 6 (6%) with endothelial dysfunction, 13 (13%) with CMD, and 18 (17%) with a mixed phenotype. Management changes occurred in 76 of 104 (73%) patients, primarily through the adjustment of antianginal therapy. Nitrates, calcium channel blockers, and β-blockers were modified in 52%, 51%, and 52% of patients, respectively. The association of CFR values derived from PET and by Thermodilution demonstrated a fair overall agreement (k = 0.39, 95% CI 0.09-0.68). Dose-response to acetylcholine (2-200 ucg) showed that diagnostic criteria were achieved with the 100 mcg dose in most participants. Invasive CFT was safe with only two safety events recorded.
Conclusions:
An invasive CFT program was safely implemented, demonstrating high diagnostic yield and an association with frequent changes in anti-anginal therapy of patients with non-obstructive coronary artery disease.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Catheterization I: Pre-Procedure Overview
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Receiver Operating Characteristic Plot
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

